← Back to Clinical Trials
Recruiting NCT06831435

NCT06831435 Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression: a Real-world Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06831435
Status Recruiting
Phase
Sponsor Peking University
Condition Depression
Study Type INTERVENTIONAL
Enrollment 325 participants
Start Date 2024-11-13
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 14 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
a digital product based on CBT

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 325 participants in total. It began in 2024-11-13 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The project proposes to develop a digital product based on cognitive behavioral therapy for the assisted treatment of depression. The digital cognitive behavioral therapy in this study is conducted based on a self-developed mobile applet. The therapy is developed by psychotherapists, which is conducted for a total of 8 weeks, with weekly sessions including AI-guided course work and homework. This study aims to evaluate the therapeutic effects of CBT-based digital products for depression in patients through a real-world study, and to explore its genetic and neuroimaging mechanisms.

Eligibility Criteria

Inclusion Criteria: 1. Aged 14-60 years (including 14 and 60), no gender restriction; 2. HAMD \>= 14; 3. Written informed consent obtained from the patient; written informed consent obtained from the guardian for minors. Exclusion Criteria: * Persons with severe suicidal tendencies (item 10 of the MADRS scale ≥ 5).

Contact & Investigator

Central Contact

Weihua Yue

✉ dryue@bjmu.edu.cn

📞 86-010-82805307

Frequently Asked Questions

Who can join the NCT06831435 clinical trial?

This trial is open to participants of all sexes, aged 14 Years or older, up to 60 Years, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06831435 currently recruiting?

Yes, NCT06831435 is actively recruiting participants. Contact the research team at dryue@bjmu.edu.cn for enrollment information.

Where is the NCT06831435 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT06831435 clinical trial?

NCT06831435 is sponsored by Peking University. The trial plans to enroll 325 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology